These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38980450)

  • 1. Metabolomics 2023 workshop report: moving toward consensus on best QA/QC practices in LC-MS-based untargeted metabolomics.
    Mosley JD; Dunn WB; Kuligowski J; Lewis MR; Monge ME; Ulmer Holland C; Vuckovic D; Zanetti KA; Schock TB;
    Metabolomics; 2024 Jul; 20(4):73. PubMed ID: 38980450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissemination and analysis of the quality assurance (QA) and quality control (QC) practices of LC-MS based untargeted metabolomics practitioners.
    Evans AM; O'Donovan C; Playdon M; Beecher C; Beger RD; Bowden JA; Broadhurst D; Clish CB; Dasari S; Dunn WB; Griffin JL; Hartung T; Hsu PC; Huan T; Jans J; Jones CM; Kachman M; Kleensang A; Lewis MR; Monge ME; Mosley JD; Taylor E; Tayyari F; Theodoridis G; Torta F; Ubhi BK; Vuckovic D;
    Metabolomics; 2020 Oct; 16(10):113. PubMed ID: 33044703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolomics 2022 workshop report: state of QA/QC best practices in LC-MS-based untargeted metabolomics, informed through mQACC community engagement initiatives.
    Dunn WB; Kuligowski J; Lewis M; Mosley JD; Schock T; Ulmer Holland C; Zanetti KA; Vuckovic D;
    Metabolomics; 2023 Nov; 19(11):93. PubMed ID: 37940740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishing a framework for best practices for quality assurance and quality control in untargeted metabolomics.
    Mosley JD; Schock TB; Beecher CW; Dunn WB; Kuligowski J; Lewis MR; Theodoridis G; Ulmer Holland CZ; Vuckovic D; Wilson ID; Zanetti KA
    Metabolomics; 2024 Feb; 20(2):20. PubMed ID: 38345679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reference materials for MS-based untargeted metabolomics and lipidomics: a review by the metabolomics quality assurance and quality control consortium (mQACC).
    Lippa KA; Aristizabal-Henao JJ; Beger RD; Bowden JA; Broeckling C; Beecher C; Clay Davis W; Dunn WB; Flores R; Goodacre R; Gouveia GJ; Harms AC; Hartung T; Jones CM; Lewis MR; Ntai I; Percy AJ; Raftery D; Schock TB; Sun J; Theodoridis G; Tayyari F; Torta F; Ulmer CZ; Wilson I; Ubhi BK
    Metabolomics; 2022 Apr; 18(4):24. PubMed ID: 35397018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards quality assurance and quality control in untargeted metabolomics studies.
    Beger RD; Dunn WB; Bandukwala A; Bethan B; Broadhurst D; Clish CB; Dasari S; Derr L; Evans A; Fischer S; Flynn T; Hartung T; Herrington D; Higashi R; Hsu PC; Jones C; Kachman M; Karuso H; Kruppa G; Lippa K; Maruvada P; Mosley J; Ntai I; O'Donovan C; Playdon M; Raftery D; Shaughnessy D; Souza A; Spaeder T; Spalholz B; Tayyari F; Ubhi B; Verma M; Walk T; Wilson I; Witkin K; Bearden DW; Zanetti KA
    Metabolomics; 2019 Jan; 15(1):4. PubMed ID: 30830465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current Practices in LC-MS Untargeted Metabolomics: A Scoping Review on the Use of Pooled Quality Control Samples.
    Broeckling CD; Beger RD; Cheng LL; Cumeras R; Cuthbertson DJ; Dasari S; Davis WC; Dunn WB; Evans AM; Fernández-Ochoa A; Gika H; Goodacre R; Goodman KD; Gouveia GJ; Hsu PC; Kirwan JA; Kodra D; Kuligowski J; Lan RS; Monge ME; Moussa LW; Nair SG; Reisdorph N; Sherrod SD; Ulmer Holland C; Vuckovic D; Yu LR; Zhang B; Theodoridis G; Mosley JD
    Anal Chem; 2023 Dec; 95(51):18645-18654. PubMed ID: 38055671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality assurance and quality control reporting in untargeted metabolic phenotyping: mQACC recommendations for analytical quality management.
    Kirwan JA; Gika H; Beger RD; Bearden D; Dunn WB; Goodacre R; Theodoridis G; Witting M; Yu LR; Wilson ID;
    Metabolomics; 2022 Aug; 18(9):70. PubMed ID: 36029375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A perspective on the standards describing mass spectrometry-based metabolic phenotyping (metabolomics/metabonomics) studies in publications.
    Wilson ID; Theodoridis G; Virgiliou C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Feb; 1164():122515. PubMed ID: 33460910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality Control and Validation Issues in LC-MS Metabolomics.
    Begou O; Gika HG; Theodoridis GA; Wilson ID
    Methods Mol Biol; 2018; 1738():15-26. PubMed ID: 29654580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LC-MS-based holistic metabolic profiling. Problems, limitations, advantages, and future perspectives.
    Gika HG; Wilson ID; Theodoridis GA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Sep; 966():1-6. PubMed ID: 24618029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MetaClean: a machine learning-based classifier for reduced false positive peak detection in untargeted LC-MS metabolomics data.
    Chetnik K; Petrick L; Pandey G
    Metabolomics; 2020 Oct; 16(11):117. PubMed ID: 33085002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and Application of an LC-MS/MS Untargeted Exposomics Method with a Separated Pooled Quality Control Strategy.
    Frigerio G; Moruzzi C; Mercadante R; Schymanski EL; Fustinoni S
    Molecules; 2022 Apr; 27(8):. PubMed ID: 35458780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mass spectrometry-based holistic analytical approaches for metabolite profiling in systems biology studies.
    Theodoridis G; Gika HG; Wilson ID
    Mass Spectrom Rev; 2011; 30(5):884-906. PubMed ID: 21384411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MARS: A Multipurpose Software for Untargeted LC-MS-Based Metabolomics and Exposomics.
    Goracci L; Tiberi P; Di Bona S; Bonciarelli S; Passeri GI; Piroddi M; Moretti S; Volpi C; Zamora I; Cruciani G
    Anal Chem; 2024 Jan; 96(4):1468-1477. PubMed ID: 38236168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The importance of experimental design and QC samples in large-scale and MS-driven untargeted metabolomic studies of humans.
    Dunn WB; Wilson ID; Nicholls AW; Broadhurst D
    Bioanalysis; 2012 Sep; 4(18):2249-64. PubMed ID: 23046267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MetaboAnalystR 4.0: a unified LC-MS workflow for global metabolomics.
    Pang Z; Xu L; Viau C; Lu Y; Salavati R; Basu N; Xia J
    Nat Commun; 2024 May; 15(1):3675. PubMed ID: 38693118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LC-MS untargeted metabolomics assesses the delayed response of glufosinate treatment of transgenic glufosinate resistant (GR) buffalo grasses (Stenotaphrum secundatum L.).
    Boonchaisri S; Rochfort S; Stevenson T; Dias DA
    Metabolomics; 2021 Feb; 17(3):28. PubMed ID: 33609206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolomic Strategies Involving Mass Spectrometry Combined with Liquid and Gas Chromatography.
    Lopes AS; Cruz EC; Sussulini A; Klassen A
    Adv Exp Med Biol; 2017; 965():77-98. PubMed ID: 28132177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Model-driven data curation pipeline for LC-MS-based untargeted metabolomics.
    Riquelme G; Bortolotto EE; Dombald M; Monge ME
    Metabolomics; 2023 Mar; 19(3):15. PubMed ID: 36856823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.